|
The S.L.E. Lupus Foundation Research Program funds research projects relevant to Lupus Erythematosus, Career Development Awards for new investigators interested in lupus research, and Extended Fellowship Awards. The Foundation's research commitments for new medical research cover scientific studies at academic medical centers in the New York City metropolitan area.
The following talented scientists received grants to support and encourage new lupus investigators, and for ongoing lupus research.
Fellowships
Ramalingam Bethunaickan, PhD
The Feinstein Institute for Medical Research
Mechanisms of remission of SLE nephritis
Qinzhong Chen, PhD
Columbia University
Novel signaling pathways in humoral autoimmunity
Joel Cohen-Solal, PhD
The Feinstein Institute for Medical Research
Estrogen and lupus susceptibility: biomarkers and genetics
Peter Izmirly, MD
NYU—Hospital for Joint Diseases
Role of the endothelium in lupus nephritis and vasculopathy
Philip Kahn, MD
Columbia University
Treatment of anti-phospholipid syndrome with BAFF blockade
Sun Jung Kim, PhD
The Feinstein Institute for Medical Research
Modulation of immature B cell development in FcRy chain deleted mice
Carolina Llanos, MD, PhD
NYU—Hospital for Joint Diseases
Impaired clearance of apoptotic cardiocytes and pathogenesis of congenital heart block: link to anti-SSA/Ro-SSB/La antibodies
Kevin Nickerson, PhD
Yale University
Examination of the role of Toll-like receptors in prompting and promoting lupus.
Mikhail Olferiev, MD
Cornell University/Hospital for Special Surgery
Altered Fc gamma receptor-dependent effector mechanisms in lupus mediated by Th1/Th2 deviation
Antigoni Triantafyllopoulou, MD
Hospital for Special Surgery
Investigation of the mechanisms are at the root of renal inflammation and the progression to fibrosis and renal failure in lupus.
Min Yang, MD
Mount Sinai School of Medicine
BAFF-induced p52 NF-kB signaling pathway as a therapeutic target in lupus
Zeguo Zhao, PhD
Albert Einstein College of Medicine
The role of TWEAK-Fn14 interactions in the pathogenesis of SLE
Career Development Awards
Giovanni Franchin, MD, PhD
The Feinstein Institute for Medical Research
Therapeutics in lupus: blocking CD40-CD40L with peptides
Guillermina Girardi, PhD
Hospital for Special Surgery
Complement inhibition and anticoagulation prevent anti-phospholipid antibody-induced pregnancy loss and thrombosis: Are these approaches different?
Venkatesh Jeganathan, PhD
Feinstein Institute for Medical Research
(North Shore Long Island Jewish Health System)
Testing of DNA-targeted therapies that hold promise for modulating the progression of lupus without suppressing the immune system, as current key therapies do.
Ingrid Mecklenbrauker, PhD
The Rockefeller University
The role of protein kinase C delta in BAFF-mediated signaling in B cells
Meera Ramanujam, PhD
The Feinstein Institute for Medical Research
Towards a better understanding of BAFF blockade using lupus-prone mice
Research Grants
Ann Haberman, PhD
Yale University
How germinal centers select high affinity B cells: determination of cellular interactions and migratory behavior via intravital microscopy
Elena Peeva, MD, MSc
Albert Einstein College of Medicine
Mechanism by which lupus-susceptibility loci SLE 3/5 confer responsiveness to prolactin
For more details on the 2007 recipients and their research work, see “More Bright Young Investigators to Research Lupus.”
For more details on the 2006 recipients and their research work, see “S.L.E. Lupus Foundation Awards Six More New Investigator Grants.”
For more details on the 2005 recipients and their research work, see “Six Additional New Investigator Grants Awarded to New York Area Scientists.”
Read about our work with the Lupus Research Institute (LRI).
|
